GENTEX director receives 5,626-share stock award
KENNEDY JOHN C reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
KENNEDY JOHN C reported acquisition or exercise transactions in this Form 4 filing.
GENTEX CORP director John C. Kennedy reported an equity award of 5,626 shares of Common Stock. The shares were granted at no cash cost to him as a compensation award and will vest 100% one year from the grant date. Following this grant, he holds 5,626 shares directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 5,626 | $0.00 | $0.00 |
Footnotes (1)
- F1. These shares vest 100% one year from grant award date.
Key Figures
Key Terms
Form 4 regulatory
Common Stock financial
Grant, award, or other acquisition financial
vest financial
direct ownership financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did GENTEX (GNTX) director John C. Kennedy report?
Was John C. Kennedy’s GENTEX Form 4 transaction a stock purchase or sale?
Does the GENTEX Form 4 for John C. Kennedy involve any stock options or derivatives?
AI-generated analysis. How Rhea-AI works. Not financial advice.